Notably, a recent report described a case of a spinal ependymoma, with poor clinical outcome and DNA methylation profile consistent with ependymoma MYCN-amplified, lacking MYCN amplification and rather harboring MYC amplification (33). This evidence concerns the gene MYCN and ependymoma.